Imperagen selected for Innovate UK’s Global Business Innovation Programme at SynBioBeta 2024

Imperagen is proud to have been selected to participate in the Innovate UK Engineering Biology Global Business Innovation Programme.

This prestigious programme brings together leading UK biotech innovators with pioneers from the U.S. synthetic biology community—including established companies, entrepreneurs, investors, and regulators—at one of the world’s premier events for biotechnology.

Our Chief Product Officer, Tim Eyes, will represent Imperagen alongside a delegation of UK biotech companies and Innovate UK leaders. The visit will focus on exploring innovation, building international relationships, and unlocking new opportunities for collaboration and market access.

“It’s a fantastic opportunity to engage with global leaders in synthetic biology and industrial biotech,” said Tim. “We’re looking forward to meaningful conversations that will help accelerate Imperagen’s mission and forge impactful partnerships across the Atlantic.”

This initiative is supported by Innovate UK, the Department for Science, Innovation and Technology, and the Department for Business and Trade, as part of a broader effort to grow the UK’s global leadership in engineering biology.